• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Different types of plasminogen activator activity in human brain tumours: relation with peritumoral oedema?

作者信息

Gijtenbeek J M, Emeis J J, van der Sande J J, Lulf R E

机构信息

Department of Neurology, Municipal Hospital Slotervaart, Amsterdam, The Netherlands.

出版信息

Clin Neurol Neurosurg. 1994 Nov;96(4):305-9. doi: 10.1016/0303-8467(94)90119-8.

DOI:10.1016/0303-8467(94)90119-8
PMID:7889692
Abstract

In 20 tissue samples from human brain tumours the concentrations were measured of (1) total plasminogen activator activity, (2) tissue-type plasminogen activator (t-PA) activity, (3) urokinase-type plasminogen activator (u-PA) activity, and (4) t-PA antigen. Most tumours contained a considerable amount of t-PA, but a high interindividual and in a few cases even an intra-individual variability was observed. A weak but significant negative correlation was found between t-PA concentration and the oedema/tumour ratio, as calculated from the preoperative computerized tomography (CT) brain scanning. No correlation was found with u-PA activity. It is concluded that t-PA and u-PA are probably not important factors in the production of peritumoral cerebral oedema, but a correlation between locally different amounts of t-PA or u-PA and the locally different extent of surrounding oedema has not yet been excluded.

摘要

相似文献

1
Different types of plasminogen activator activity in human brain tumours: relation with peritumoral oedema?
Clin Neurol Neurosurg. 1994 Nov;96(4):305-9. doi: 10.1016/0303-8467(94)90119-8.
2
Histochemical study of alkaline phosphatase in primary human brain tumors: diagnostic implications for meningiomas and neurinomas.原发性人脑肿瘤中碱性磷酸酶的组织化学研究:对脑膜瘤和神经鞘瘤的诊断意义
Neurosurgery. 1993 Feb;32(2):180-4; discussion 184. doi: 10.1227/00006123-199302000-00005.
3
Postoperative venous thromboembolism and brain tumors: Part III. Biochemical profile.术后静脉血栓栓塞与脑肿瘤:第三部分。生化指标
J Neurooncol. 1992 Oct;14(2):113-8. doi: 10.1007/BF00177614.
4
Proliferating cell nuclear antigen (PCNA) immunostaining as an alternative to bromodeoxyuridine (BrdU) immunostaining for brain tumours in paraffin embedded sections.增殖细胞核抗原(PCNA)免疫染色作为石蜡包埋切片中脑肿瘤溴脱氧尿苷(BrdU)免疫染色的替代方法。
Acta Neurochir (Wien). 1992;117(3-4):178-81. doi: 10.1007/BF01400617.
5
Production of urokinase-type plasminogen activator (u-PA) and plasminogen activator inhibitor-1 (PAI-1) in human brain tumours.人脑肿瘤中尿激酶型纤溶酶原激活物(u-PA)和纤溶酶原激活物抑制剂-1(PAI-1)的产生。
Acta Neurochir (Wien). 1998;140(4):377-85; discussion 385-6. doi: 10.1007/s007010050112.
6
Tumor prostaglandin levels correlate with edema around supratentorial meningiomas.肿瘤前列腺素水平与幕上脑膜瘤周围的水肿相关。
Neurosurgery. 1993 Aug;33(2):204-10; discussion 211.
7
Tenascin distribution in human brain tumours.腱生蛋白在人脑肿瘤中的分布。
Acta Neurochir (Wien). 1995;136(1-2):44-50. doi: 10.1007/BF01411434.
8
Plasminogen activators and plasminogen activator inhibitors in blood and tumour fluids of patients with ovarian cancer.卵巢癌患者血液和肿瘤液中的纤溶酶原激活剂及纤溶酶原激活剂抑制剂
Eur J Cancer. 1994;30A(9):1302-9. doi: 10.1016/0959-8049(94)90178-3.
9
[The study of plasminogen activator in renal cell carcinoma with special remarks on urokinase type plasminogen activator].
Nihon Hinyokika Gakkai Zasshi. 1989 Nov;80(11):1558-65. doi: 10.5980/jpnjurol1989.80.1558.
10
Plasminogen activators in endoscopic biopsies as indicators of gastrointestinal cancer: comparison with resection specimens.内镜活检中纤溶酶原激活剂作为胃肠道癌指标的研究:与切除标本的比较
Br J Cancer. 1989 Sep;60(3):397-400. doi: 10.1038/bjc.1989.293.

引用本文的文献

1
Cerebrospinal fluid plasminogen activator inhibitor-1 in patients with neurological disease.神经系统疾病患者脑脊液中的纤溶酶原激活物抑制剂-1
J Clin Pathol. 1997 Feb;50(2):157-60. doi: 10.1136/jcp.50.2.157.
2
Cerebrospinal fluid activity of tissue plasminogen activator in patients with neurological diseases.神经系统疾病患者脑脊液中组织型纤溶酶原激活物的活性
J Clin Pathol. 1996 Jul;49(7):577-80. doi: 10.1136/jcp.49.7.577.